ID: ALA4789673

Max Phase: Preclinical

Molecular Formula: C35H41BrF3N7O7

Molecular Weight: 694.63

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N/C(=N/C(=O)NCCNC(=O)CCBr)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C33H40BrN7O5.C2HF3O2/c34-18-17-28(43)36-20-21-38-33(46)41-32(35)37-19-7-12-27(30(44)39-22-23-13-15-26(42)16-14-23)40-31(45)29(24-8-3-1-4-9-24)25-10-5-2-6-11-25;3-2(4,5)1(6)7/h1-6,8-11,13-16,27,29,42H,7,12,17-22H2,(H,36,43)(H,39,44)(H,40,45)(H4,35,37,38,41,46);(H,6,7)/t27-;/m1./s1

Standard InChI Key:  TXFPZKULVKWTEP-HZPIKELBSA-N

Associated Targets(Human)

Neuropeptide Y receptor type 1 5019 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 694.63Molecular Weight (Monoisotopic): 693.2274AlogP: 2.62#Rotatable Bonds: 16
Polar Surface Area: 187.04Molecular Species: BASEHBA: 5HBD: 7
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.49CX Basic pKa: 8.96CX LogP: 1.79CX LogD: 0.68
Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.05Np Likeness Score: -0.36

References

1. Buschmann, Jonas, Seiler, Theresa, Bernhardt, Gunther, Keller, Max, Wifling, David.  (2020)  Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of Nomega-carbamoyl substituents determines Y1R binding mode and affinity,  11  (2): [PMID:33479634] [10.1039/c9md00538b]

Source